This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (271)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Cardiovascular System  • Prognosis/ Outcomes  • Congestive Heart Failure/ Cardiomyopathy  • Alert me on articles by topic  Social Bookmarking   What's this?

Derivation and Validation of a Clinical Model

Douglas S. Lee, MD; Peter C. Austin, PhD; Jean L. Rouleau, MD; Peter P. Liu, MD; David Naimark, MD; Jack V. Tu, MD, PhD

JAMA. 2003;290:2581-2587.

Context  A predictive model of mortality in heart failure may be useful for clinicians to improve communication with and care of hospitalized patients.

Objectives  To identify predictors of mortality and to develop and to validate a model using information available at hospital presentation.

Design, Setting, and Participants  Retrospective study of 4031 community-based patients presenting with heart failure at multiple hospitals in Ontario, Canada (2624 patients in the derivation cohort from 1999-2001 and 1407 patients in the validation cohort from 1997-1999), who had been identitifed as part of the Enhanced Feedback for Effective Cardiac Treatment (EFFECT) study.

Main Outcome Measures  All-cause 30-day and 1-year mortality.

Results  The mortality rates for the derivation cohort and validation cohort, respectively, were 8.9% and 8.2% in hospital, 10.7% and 10.4% at 30 days, and 32.9% and 30.5% at 1 year. Multivariable predictors of mortality at both 30 days and 1 year included older age, lower systolic blood pressure, higher respiratory rate, higher urea nitrogen level (all P<.001), and hyponatremia (P<.01). Comorbid conditions associated with mortality included cerebrovascular disease (30-day mortality odds ratio [OR], 1.43; 95% confidence interval [CI], 1.03-1.98; P = .03), chronic obstructive pulmonary disease (OR, 1.66; 95% CI, 1.22-2.27; P = .002), hepatic cirrhosis (OR, 3.22; 95% CI, 1.08-9.65; P = .04), dementia (OR, 2.54; 95% CI, 1.77-3.65; P<.001), and cancer (OR, 1.86; 95% CI, 1.28-2.70; P = .001). A risk index stratified the risk of death and identified low- and high-risk individuals. Patients with very low-risk scores (60) had a mortality rate of 0.4% at 30 days and 7.8% at 1 year. Patients with very high-risk scores (>150) had a mortality rate of 59.0% at 30 days and 78.8% at 1 year. Patients with higher 1-year risk scores had reduced survival at all times up to 1 year (log-rank, P<.001). For the derivation cohort, the area under the receiver operating characteristic curve for the model was 0.80 for 30-day mortality and 0.77 for 1-year mortality. Predicted mortality rates in the validation cohort closely matched observed rates across the entire spectrum of risk.

Conclusions  Among community-based heart failure patients, factors identifiable within hours of hospital presentation predicted mortality risk at 30 days and 1 year. The externally validated predictive index may assist clinicians in estimating heart failure mortality risk and in providing quantitative guidance for decision making in heart failure care.

Author Affiliations: Departments of Health Policy, Management, and Evaluation/Clinical Epidemiology (Drs Lee, Austin, and Tu) and Public Health Sciences (Drs Austin and Tu), Division of Cardiology, University Health Network–Toronto General Hospital and Mt Sinai Hospital (Drs Rouleau and Liu), Heart and Stroke/Richard Lewar Centre of Excellence and Toronto General Hospital (Dr Liu), University of Toronto, Toronto, Ontario; Institute for Clinical Evaluative Sciences, Toronto, Ontario (Drs Lee, Austin, and Tu); and Department of Medicine, Sunnybrook and Women's College Health Science Centre, Toronto, Ontario (Drs Naimark and Tu).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Hospitalizations in patients with heart failure: who and why.
Setoguchi and Stevenson
J Am Coll Cardiol 2009;54:1703-1705.
FULL TEXT  

Reduced in-hospital mortality for heart failure with clinical pathways: the results of a cluster randomised controlled trial
Panella et al.
Qual Saf Health Care 2009;18:369-373.
ABSTRACT | FULL TEXT  

Development and validation of a clinical index to predict survival after cardiac resynchronisation therapy
Leyva et al.
Heart 2009;95:1619-1625.
ABSTRACT | FULL TEXT  

Quality of care for atrial fibrillation among patients hospitalized for heart failure.
Piccini et al.
J Am Coll Cardiol 2009;54:1280-1289.
ABSTRACT | FULL TEXT  

Maximizing Survival Benefit With Primary Prevention Implantable Cardioverter-Defibrillator Therapy in a Heart Failure Population
Levy et al.
Circulation 2009;120:835-842.
ABSTRACT | FULL TEXT  

Are Multiple Biomarker Testing Strategies Ready for Prime Time in Heart Failure?
Lee and Tu
Circ Heart Fail 2009;2:387-388.
FULL TEXT  

Validation of a prediction rule for development of rheumatoid arthritis in patients with early undifferentiated arthritis
Kuriya et al.
Ann Rheum Dis 2009;68:1482-1485.
ABSTRACT | FULL TEXT  

Palliative care in congestive heart failure.
Goodlin
J Am Coll Cardiol 2009;54:386-396.
ABSTRACT | FULL TEXT  

Effects of Neuromuscular Electrical Stimulation of Muscles of Ambulation in Patients With Chronic Heart Failure or COPD: A Systematic Review of the English-Language Literature
Sillen et al.
Chest 2009;136:44-61.
ABSTRACT | FULL TEXT  

Relation of Disease Pathogenesis and Risk Factors to Heart Failure With Preserved or Reduced Ejection Fraction: Insights From the Framingham Heart Study of the National Heart, Lung, and Blood Institute
Lee et al.
Circulation 2009;119:3070-3077.
ABSTRACT | FULL TEXT  

The MUSIC Risk score: a simple method for predicting mortality in ambulatory patients with chronic heart failure
Vazquez et al.
Eur Heart J 2009;30:1088-1096.
ABSTRACT | FULL TEXT  

Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology
Jaarsma et al.
Eur J Heart Fail 2009;11:433-443.
ABSTRACT | FULL TEXT  

Evaluation for a Ventricular Assist Device: Selecting the Appropriate Candidate
Wilson et al.
Circulation 2009;119:2225-2232.
FULL TEXT  

Maximum potential benefit of implantable defibrillators in preventing sudden death after hospital admission because of heart failure
Setoguchi et al.
CMAJ 2009;180:611-616.
ABSTRACT | FULL TEXT  

Years-needed-to-treat to add 1 year of life: a new metric to estimate treatment effects in randomized trials
Levy et al.
Eur J Heart Fail 2009;11:256-263.
ABSTRACT | FULL TEXT  

Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide
Wedel et al.
Eur J Heart Fail 2009;11:281-291.
ABSTRACT | FULL TEXT  

Acute heart failure syndromes.
Gheorghiade and Pang
J Am Coll Cardiol 2009;53:557-573.
ABSTRACT | FULL TEXT  

Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II
Komajda et al.
Eur Heart J 2009;30:478-486.
ABSTRACT | FULL TEXT  

Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology
Hawkins et al.
Eur J Heart Fail 2009;11:130-139.
ABSTRACT | FULL TEXT  

Utility of the Seattle heart failure model in patients with advanced heart failure.
Kalogeropoulos et al.
J Am Coll Cardiol 2009;53:334-342.
ABSTRACT | FULL TEXT  

Loop Diuretics in Acute Decompensated Heart Failure: Necessary? Evil? A Necessary Evil?
Felker et al.
Circ Heart Fail 2009;2:56-62.
FULL TEXT  

Challenges of Noncancer Patients Transitioning to Hospice
Brunker
Home Health Care Management Practice 2008;20:400-403.
ABSTRACT  

Predictors of In-Hospital Mortality in Patients Hospitalized for Heart Failure: Insights From the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF)
Abraham et al.
J Am Coll Cardiol 2008;52:347-356.
ABSTRACT | FULL TEXT  

Transcriptomic Biomarkers for Individual Risk Assessment in New-Onset Heart Failure
Heidecker et al.
Circulation 2008;118:238-246.
ABSTRACT | FULL TEXT  

Statistical Models and Patient Predictors of Readmission for Heart Failure: A Systematic Review
Ross et al.
Arch Intern Med 2008;168:1371-1386.
ABSTRACT | FULL TEXT  

Does It Matter Why and How Patients With Heart Failure Die?: A Debate That Lives On
Hauptman
Circ Heart Fail 2008;1:89-90.
FULL TEXT  

Depression worsens outcomes in elderly patients with heart failure: An analysis of 48,117 patients in a community setting
Macchia et al.
Eur J Heart Fail 2008;10:714-721.
ABSTRACT | FULL TEXT  

Discordance Between Patient-Predicted and Model-Predicted Life Expectancy Among Ambulatory Patients With Heart Failure
Allen et al.
JAMA 2008;299:2533-2542.
ABSTRACT | FULL TEXT  

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons
Epstein et al.
J Am Coll Cardiol 2008;51:e1-e62.
FULL TEXT  

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons
Writing Committee Members et al.
Circulation 2008;117:e350-e408.
FULL TEXT  

The Year in Hypertension
Williams
J Am Coll Cardiol 2008;51:1803-1817.
FULL TEXT  

Effect of different angiotensin-converting-enzyme inhibitors on mortality among elderly patients with congestive heart failure
Pilote et al.
CMAJ 2008;178:1303-1311.
ABSTRACT | FULL TEXT  

Admission or Changes in Renal Function During Hospitalization for Worsening Heart Failure Predict Postdischarge Survival: Results From the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF)
Klein et al.
Circ Heart Fail 2008;1:25-33.
ABSTRACT | FULL TEXT  

Effect of Baseline and Changes in Systolic Blood Pressure Over Time on the Effectiveness of Valsartan in the Valsartan Heart Failure Trial
Anand et al.
Circ Heart Fail 2008;1:34-42.
ABSTRACT | FULL TEXT  

End-of-Life Care in the Critical Care Unit for Patients With Heart Failure
Wingate and Wiegand
Crit Care Nurse 2008;28:84-94.
FULL TEXT  

Predicting mortality among a general practice-based sample of older people with heart failure
Barnes et al.
Chronic Illness 2008;4:5-12.
ABSTRACT  

Heart failure in the elderly: How risky is it to be discharged?
Nieminen and Harjola
Eur J Heart Fail 2008;10:222-223.
FULL TEXT  

Acute heart failure in the emergency department: Short and long-term outcomes of elderly patients with heart failure
Ezekowitz et al.
Eur J Heart Fail 2008;10:308-314.
ABSTRACT | FULL TEXT  

Hyponatraemia in acute heart failure is a marker of increased mortality but not when associated with hyperglycaemia
Milo-Cotter et al.
Eur J Heart Fail 2008;10:196-200.
ABSTRACT | FULL TEXT  

Effect of Antecedent Hypertension and Follow-Up Blood Pressure on Outcomes After High-Risk Myocardial Infarction
Thune et al.
Hypertension 2008;51:48-54.
ABSTRACT | FULL TEXT  

Characteristics of Patients Hospitalized With Acute Decompensated Heart Failure Who Are Referred for Hospice Care
Hauptman et al.
Arch Intern Med 2007;167:1990-1997.
ABSTRACT | FULL TEXT  

Sex and Racial Differences in the Use of Implantable Cardioverter-Defibrillators Among Patients Hospitalized With Heart Failure
Hernandez et al.
JAMA 2007;298:1525-1532.
ABSTRACT | FULL TEXT  

Obesity and Stroke After Cardiac Surgery: The Impact of Grouping Body Mass Index
Filardo et al.
Ann. Thorac. Surg. 2007;84:720-722.
FULL TEXT  

Ejection fraction and blood pressure are important and interactive predictors of 4-week mortality in severe acute heart failure
Adamopoulos et al.
Eur J Heart Fail 2007;9:935-941.
ABSTRACT | FULL TEXT  

The prognostic influence of chronic obstructive pulmonary disease in patients hospitalised for chronic heart failure
Macchia et al.
Eur J Heart Fail 2007;9:942-948.
ABSTRACT | FULL TEXT  

On the Fledgling Field of Mechanical Circulatory Support
Stevenson and Couper
J Am Coll Cardiol 2007;50:748-751.
FULL TEXT  

The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T
Metra et al.
Eur J Heart Fail 2007;9:776-786.
ABSTRACT | FULL TEXT  

Prediction of Mode of Death in Heart Failure: The Seattle Heart Failure Model
Mozaffarian et al.
Circulation 2007;116:392-398.
ABSTRACT | FULL TEXT  

Vasopressin Dysregulation and Hyponatremia in Hospitalized Patients
Multz
J Intensive Care Med 2007;22:216-223.
ABSTRACT  

Effect of Cardiac and Noncardiac Conditions on Survival After Defibrillator Implantation
Lee et al.
J Am Coll Cardiol 2007;49:2408-2415.
ABSTRACT | FULL TEXT  

N-Terminal Pro-B-Type Natriuretic Peptide Testing Improves the Management of Patients With Suspected Acute Heart Failure: Primary Results of the Canadian Prospective Randomized Multicenter IMPROVE-CHF Study
Moe et al.
Circulation 2007;115:3103-3110.
ABSTRACT | FULL TEXT  

Management of octogenarians hospitalized for heart failure in Euro Heart Failure Survey I
Komajda et al.
Eur Heart J 2007;28:1310-1318.
ABSTRACT | FULL TEXT  

Angiotensin-converting enzyme inhibitors and survival in women and men with heart failure
Keyhan et al.
Eur J Heart Fail 2007;9:594-601.
ABSTRACT | FULL TEXT  

Sex differences in the effectiveness of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in patients with congestive heart failure -- A population study
Hudson et al.
Eur J Heart Fail 2007;9:602-609.
ABSTRACT | FULL TEXT  

Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology
Metra et al.
Eur J Heart Fail 2007;9:684-694.
ABSTRACT | FULL TEXT  

Carbohydrate antigen 125: an emerging prognostic risk factor in acute heart failure?
Nunez et al.
Heart 2007;93:716-721.
ABSTRACT | FULL TEXT  

Hyponatremia: Current Treatment Strategies and the Role of Vasopressin Antagonists
Cawley
The Annals of Pharmacotherapy 2007;41:840-850.
ABSTRACT | FULL TEXT  

Derivation and Validation of a Simplified Predictive Index for Renal Replacement Therapy After Cardiac Surgery
Wijeysundera et al.
JAMA 2007;297:1801-1809.
ABSTRACT | FULL TEXT  

Hyponatraemia in heart failure: a call for redefinition
Ghali
Eur Heart J 2007;0:ehm046v1-2.
FULL TEXT  

Inverse Relationship of Blood Pressure Levels to Sudden Cardiac Mortality and Benefit of the Implantable Cardioverter-Defibrillator in Patients With Ischemic Left Ventricular Dysfunction
Goldenberg et al.
J Am Coll Cardiol 2007;49:1427-1433.
ABSTRACT | FULL TEXT  

Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry
Gheorghiade et al.
Eur Heart J 2007;28:980-988.
ABSTRACT | FULL TEXT  

International variations in the treatment and co-morbidity of left ventricular systolic dysfunction: Data from the EuroHeart Failure Survey
Lainscak et al.
Eur J Heart Fail 2007;9:292-299.
ABSTRACT | FULL TEXT  

Regional Differences in Process of Care and Outcomes for Older Acute Myocardial Infarction Patients in the United States and Ontario, Canada
Ko et al.
Circulation 2007;115:196-203.
ABSTRACT | FULL TEXT  

Enhancement of Claims Data to Improve Risk Adjustment of Hospital Mortality
Pine et al.
JAMA 2007;297:71-76.
ABSTRACT | FULL TEXT  

Blood Pressure in Heart Failure: A Love-Hate Relationship
Pfeffer
J Am Coll Cardiol 2007;49:40-42.
FULL TEXT  

Risk Factors for Mortality in Middle-aged Women
Tice et al.
Arch Intern Med 2006;166:2469-2477.
ABSTRACT | FULL TEXT  

Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure.
Gheorghiade et al.
JAMA 2006;296:2217-2226.
ABSTRACT | FULL TEXT  

Non-steroidal anti-inflammatory drugs and risk of first hospital admission for heart failure in the general population
Huerta et al.
Heart 2006;92:1610-1615.
ABSTRACT | FULL TEXT  

Diagnostic Usefulness of B-Type Natriuretic Peptide and Functional Consequences of Muscle Alterations in COPD and Chronic Heart Failure.
Jelic and Le Jemtel
Chest 2006;130:1220-1230.
ABSTRACT | FULL TEXT  

Prediction of mortality of patients with suspected heart failure by brain natriuretic peptide concentrations > 100 pg/ml: comparison of a clinical model with brain natriuretic peptide concentrations.
Kellett
Heart 2006;92:1512-1513.
FULL TEXT  

Long-term Survival in Elderly Patients Hospitalized for Heart Failure: 14-Year Follow-up From a Prospective Randomized Trial.
Huynh et al.
Arch Intern Med 2006;166:1892-1898.
ABSTRACT | FULL TEXT  

Admission Blood Glucose Level and Mortality Among Hospitalized Nondiabetic Patients With Heart Failure.
Barsheshet et al.
Arch Intern Med 2006;166:1613-1619.
ABSTRACT | FULL TEXT  

Severe hyponatraemia in medical in-patients: aetiology, assessment and outcome
Clayton et al.
QJM 2006;99:505-511.
ABSTRACT | FULL TEXT  

Outcome of heart failure with preserved ejection fraction in a population-based study.
Bhatia et al.
NEJM 2006;355:260-269.
ABSTRACT | FULL TEXT  

Aspirin Use and Outcomes in a Community-Based Cohort of 7352 Patients Discharged After First Hospitalization for Heart Failure
McAlister et al.
Circulation 2006;113:2572-2578.
ABSTRACT | FULL TEXT  

Serum urea nitrogen, creatinine, and estimators of renal function: mortality in older patients with cardiovascular disease.
Smith et al.
Arch Intern Med 2006;166:1134-1142.
ABSTRACT | FULL TEXT  

Renal Impairment and Outcomes in Heart Failure: Systematic Review and Meta-Analysis
Smith et al.
J Am Coll Cardiol 2006;47:1987-1996.
ABSTRACT | FULL TEXT  

Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations
Vasan
Circulation 2006;113:2335-2362.
FULL TEXT  

Nationwide survey on acute heart failure in cardiology ward services in Italy
Tavazzi et al.
Eur Heart J 2006;27:1207-1215.
ABSTRACT | FULL TEXT  

Aquaretic Effect of Lixivaptan, an Oral, Non-Peptide, Selective V2 Receptor Vasopressin Antagonist, in New York Heart Association Functional Class II and III Chronic Heart Failure Patients
Abraham et al.
J Am Coll Cardiol 2006;47:1615-1621.
ABSTRACT | FULL TEXT  

An Administrative Claims Model Suitable for Profiling Hospital Performance Based on 30-Day Mortality Rates Among Patients With Heart Failure
Krumholz et al.
Circulation 2006;113:1693-1701.
ABSTRACT | FULL TEXT  

The Seattle Heart Failure Model: Prediction of Survival in Heart Failure
Levy et al.
Circulation 2006;113:1424-1433.
ABSTRACT | FULL TEXT  

Translating Clinical Research into Clinical Practice: Impact of Using Prediction Rules To Make Decisions
Reilly and Evans
ANN INTERN MED 2006;144:201-209.
ABSTRACT | FULL TEXT  

How many patients with heart failure are eligible for cardiac resynchronization? Insights from two prospective cohorts
McAlister et al.
Eur Heart J 2006;27:323-329.
ABSTRACT | FULL TEXT